Editorials
Do calcium channel autoantibodies cause cerebellar ataxia with Lambert–Eaton syndrome?
Colin F. Fletcher PhD,
Vanda A. Lennon MD, PhD,
Colin F. Fletcher PhD
Department of Cell Biology, Scripps Research Institute, La Jolla, CA
Genomics Institute of the Novartis Research Foundation, San Diego, CA
Search for more papers by this authorVanda A. Lennon MD, PhD
Departments of Immunology, Neurology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Search for more papers by this authorColin F. Fletcher PhD,
Vanda A. Lennon MD, PhD,
Colin F. Fletcher PhD
Department of Cell Biology, Scripps Research Institute, La Jolla, CA
Genomics Institute of the Novartis Research Foundation, San Diego, CA
Search for more papers by this authorVanda A. Lennon MD, PhD
Departments of Immunology, Neurology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Search for more papers by this author
References
- 1 Eaton LM, Lambert EH. Electromyography and electrical stimulation of nerves in diseases of motor unit. Observations on myasthenic syndrome associated with malignant tumors. JAMA 1957; 163: 1117–1124.
- 2 Satoyoshi E, Kowa H, Fukunaga N. Subacute cerebellar degeneration and Eaton-Lambert syndrome with bronchogenic carcinoma. A case report. Neurology 1973; 23: 764–768.
- 3
Harper CM,
Lennon VA.
Lambert-Eaton syndrome. In:
HJ Kaminski, ed.
Current clinical neurology: myasthenia gravis and related disorders.
Totowa, NJ:
Humana Press,
2002:
269–291.
10.1385/1-59259-341-0:269 Google Scholar
- 4 Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in Lambert-Eaton myasthenic syndrome and other paraneoplastic syndromes. N Engl J Med 1995; 332: 1467–1474.
- 5 Lennon VA, Kryzer TJ. Correspondence: neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or “anti-Yo”). Neurology 1998; 51: 327–329.
- 6 Fukanaga H, Engel AG, Osame M, Lambert EH. Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1982; 5: 686–697.
- 7 Nagel A, Engel AG, Lang B, et al. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation. Ann Neurol 1988; 24: 552–558.
- 8 Waterman SA. Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Clin Auton Res 2001; 11: 145–154.
- 9 Albert ML, Darnell JC, Bender A, et al. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 1998; 4: 1321–1324.
- 10 Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002; 25: 313–319.
- 11 Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001; 49: 146–154.
- 12 Fukuda T, Motomura M, Nakao Y, et al. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert–Eaton myasthenic syndrome. Ann Neurol 2003; 53: 21–28.
- 13 Pietrobon, D. Calcium channels and channelopathies of the central nervous system. Mol Neurobiol 2002; 25: 31–50.
- 14 Fletcher CF, Tottene A, Lennon VA, et al. Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity. FASEB J 2001; 15: 1288–1290. [Published online March 5, 2001 (http://www.fasebj.org/cgi/doi/10.1096/fj.00-0562fje).
Citing Literature
